Clinical Trials List
Protocol NumberLT3001-206
Not yet recruiting
2026-06-01 - 2027-12-31
Phase II
-
Sponsor
-
Trial scale
Taiwan Multiple Center
-
Update
2026/06/01
Investigators and Locations
Co-Principal Investigator
- 張芳慈 Division of Neurology
- 許乾盛 Division of Neurology
- Wei-Shih Huang Division of Neurology
- Ching-Hua Lu Lu Division of Neurology
- 林昀 Division of Neurology
- Kang-Hsu Lin Division of Neurology
- 張育嘉 Division of Neurology
- Wei-Chung Wang Division of Neurology
- 黃詩潔 Division of Neurology
- 林欽揚 Division of Neurology
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
10 participants
